In regards to the CRC subtypes, KRAS is found mutated in a substantial number of cases in CRCs, with a particular increased prevalence in MSS, however this prevalence decreases if only MSI CRC cases are studied (66). This evidence concerns the gene KRAS and colorectal carcinoma.